首页 | 本学科首页   官方微博 | 高级检索  
检索        


A 90-day oral (dietary) toxicity study of the 2R,4R-isomer of monatin salt in Sprague–Dawley rats
Authors:J Hlywka  WA Brathwaite  MO Rihner  AI Nikiforov  AK Eapen
Institution:aCargill, Inc.,15407 McGinty Road West, Wayzata, MN 55391, USA;bToxicology Regulatory Services, Charlottesville, VA, USA;cWIL Research Laboratories, Ashland, OH, USA
Abstract:The root bark of Sclerochitin ilicifolius contains an intensely sweet substance analytically identified as isomers of 2-hydroxy-2-(indol-3-ylmethyl)-4-aminoglutaric acid and generically coined “monatin.” Groups of male and female Crl:CD(SD) rats were fed 0 (control), 5000, 10,000, 20,000 or 35,000 ppm R,R-monatin salt in the diet for 90 days. There were no toxicologically relevant clinical or histopathological findings in any of the test article-treated groups. Significantly lower cumulative body weight gains were noted in the 35,000 ppm group. Mean body weights in the 35,000 ppm group males and females were 7% and 12% lower, respectively, than the control group at study week 13. In the absence of other observations associated with systemic toxicity and lower food consumption, the magnitude of the body weight difference in the 35,000 ppm group females relative to the control group exceeded 10%, which indicated attainment of a maximum tolerated dose (MTD) level. Based on the results of this study, and conservatively assuming the body weight observations at the MTD to be indicative of an adverse effect, the dietary no-observed-adverse-effect level (NOAEL) of R,R-monatin salt for 90 days was 20,000 ppm in female rats (approximately 1544 mg/kg bw/day) and 35,000 ppm in male rats (approximately 2368 mg/kg bw/day).
Keywords:Abbreviations: ANOVA  analysis of variance  APTT  activated partial thromboplastin time  FDA  United States Food and Drug Administration  FOB  functional observational battery  HDW  hemoglobin distribution width  MCH  mean corpuscular hemoglobin  MCHC  mean corpuscular hemoglobin concentration  MCV  mean corpuscular volume  MTD  maximum tolerated dose  NOAEL  no-observed-adverse-effect level  OECD  Organisation for Economic Cooperation and Development  PT  prothrombin time  RANOVA  repeated measures of analysis of variance  RDW  red cell distribution width
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号